Omeros | OMER - Процентные расходы





Процентные расходы Изменить Дата
Adma Biologics USD 1.63M 54K 2025-12
Alnylam Pharmaceuticals USD 129.34M 84.94M 2025-12
BioMarin Pharmaceutical USD 2.78M 199K 2025-12
Cytokinetics USD 30.33M 4.01M 2025-12
Gilead Sciences USD 255M 1000K 2025-12
Heron Therapeutics USD 600K 100K 2024-12
Immunic 400K 400K 2024-12
Insmed USD 20.6M 217K 2025-12
Knight Therapeutics CAD 3.92M 1.56M 2025-12
MacroGenics USD 3.34M 2.54M 2025-09
Omeros USD 4.05M 5.16M 2024-09
Pacira USD 3.89M 387K 2025-12
Pfizer USD 711M 59M 2025-12
Rockwell Medical USD 232K 199K 2024-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
United Therapeutics USD 3.1M 100K 2025-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12
Xoma USD 3.4M 150K 2024-06